Kinetics of Serum β-D-Glucan after Pneumocystis Pneumonia Treatment in Patients with AIDS

Serum (1→3) β‐D‐Glucan as a Noninvasive Adjunct Marker for the Diagnosis and Follow‐Up ofPneumocystis jiroveciPneumonia in Patients with HIV Infection

(2010) Amalia del Palacio et al.   CLINICAL INFECTIOUS DISEASES

Serum (1 → 3)-β-d-glucan measurement as an early indicator of Pneumocystis jirovecii pneumonia and evaluation of its prognostic value

(2010) J. Held et al.   CLINICAL MICROBIOLOGY AND INFECTION

Pneumocystis jiroveciiinfection: Cell wall (1→3)-β-D-glucan biology and diagnostic utility

(2010) Malcolm A. Finkelman   CRITICAL REVIEWS IN MICROBIOLOGY

β-d-Glucan and S-adenosylmethionine serum levels for the diagnosis of Pneumocystis pneumonia in HIV-negative Patients: A prospective study

(2010) Mark G.J. de Boer et al.   JOURNAL OF INFECTION

Serum (1→3) β‐d‐Glucan as a Noninvasive Adjunct Marker for the Diagnosis ofPneumocystisPneumonia in Patients with AIDS

(2009) Tamayo Watanabe et al.   CLINICAL INFECTIOUS DISEASES

Clinical Utility of Serum β-D-Glucan and KL-6 Levels in Pneumocystis jirovecii Pneumonia

(2009) Hideta Nakamura et al.   INTERNAL MEDICINE

Serum (1-3)- -D-Glucan as a Tool for Diagnosis of Pneumocystis jirovecii Pneumonia in Patients with Human Immunodeficiency Virus Infection or Hematological Malignancy

(2009) S. Desmet et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Use of a Serum (1→3)‐β‐d‐Glucan Assay for Diagnosis and Follow‐Up ofPneumocystis jiroveciPneumonia

(2008) María Soledad Cuétara et al.   CLINICAL INFECTIOUS DISEASES

Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy

(2008) Shunsuke Mori et al.   Modern Rheumatology